File download
Send files
Remove all

Admescope Blog

Responsible treatment of laboratory animals

17 October 2019

Admescope has always been committed to advance the ethical use of animals in science and to demonstrate its significance, in March 2019 we applied for an accreditation by AAALAC International. The accreditation stands for high quality animal care and use in research organisations, where the primary standards and legislation are followed.
Read more
Tags: , in vivo DMPK

Metabolites in safety testing (MIST)

5 February 2019

After administration into a body, the drug is usually metabolised into metabolites, which may also be associated with toxic effects. This is why the MIST strategy has evolved to ensure that human metabolites have been adequately covered in the preclinical safety studies. Admescope site manager Sweden Dr Johanna Haglund will describe how to tackle this question.
Read more
Tags: , in vivo DMPK

Microsampling in in vivo PK studies

5 July 2018

Microsampling technology in drug discovery and development has been gaining a serious foothold within the industry over the last decade. We at Admescope have been providing microsampling as a part of our in vivo PK services for well over a year now and this feels like a good time to let Dr Janne Mannila, our Head of In vivo PK studies share his experiences with microsampling over an interview.
Read more
Tags: , in vivo DMPK

Establishing new in vivo lab

1 November 2016

It has been an interesting last couple of months at Admescope. Even though summer is often considered to be the quiet period in the pharmaceutical industry in Europe, we were busy at generating validation data for our new in vivo lab, which was officially opened in September.
Read more
Tags: , in vivo DMPK